🩺 Erythema Multiforme–Stevens-Johnson Syndrome Treatment: Timely Care for Severe Skin Reactions
HOOK
Skin reactions can range from mild rashes to life-threatening emergencies. While Erythema multiforme and Stevens-Johnson syndrome may appear similar, they are distinct conditions with different severity and management strategies. Prompt diagnosis and appropriate treatment are essential, particularly for Stevens-Johnson syndrome (SJS).
OVERVIEW
Erythema Multiforme (EM)
Commonly associated with infections, especially Herpes simplex
Characterized by classic "target" skin lesions
Usually self-limiting and less severe than SJS
Stevens-Johnson Syndrome (SJS)
Most often triggered by medications, although infections may also be responsible
Causes widespread skin and mucosal blistering and detachment
Requires urgent hospitalization and multidisciplinary medical care
TREATMENT APPROACHES
Erythema Multiforme Treatment
Identify and manage the underlying trigger
Symptomatic relief with pain management and skin care
Topical corticosteroids for selected patients with localized symptoms
Antiviral therapy for recurrent herpes simplex-associated EM when appropriate
Adequate hydration and monitoring for complications
Stevens-Johnson Syndrome Treatment
Immediate discontinuation of the suspected causative medication
Hospital admission, often to an intensive care or specialized burn unit
Careful fluid and electrolyte replacement
Comprehensive wound and skin care
Nutritional support and pain management
Specialized care for eye, oral, and genital involvement
Prevention and treatment of secondary infections when indicated
ADVANCED MANAGEMENT
Depending on the patient's condition and specialist evaluation, treatment may include:
Immunomodulatory therapies in selected patients
Close monitoring for respiratory, kidney, and liver complications
Ophthalmology consultation for eye involvement to reduce the risk of long-term vision problems
Rehabilitation and long-term follow-up for patients recovering from severe disease
The use of systemic corticosteroids, intravenous immunoglobulin (IVIG), or other immunomodulatory treatments varies based on the clinical situation and institutional practice, and should be guided by experienced specialists.
BENEFITS OF EARLY TREATMENT
✔ Reduces the risk of life-threatening complications✔ Enables prompt removal of the triggering medication when applicable✔ Improves symptom control and supportive care✔ Helps preserve skin, eye, and mucosal function✔ Improves the likelihood of recovery, particularly in severe SJS
PATIENT CARE TIPS
Seek immediate emergency medical care if a rash is accompanied by fever, blistering, mouth sores, eye pain, or skin peeling.
Never restart a medication suspected of causing SJS unless specifically instructed by a healthcare professional.
Inform all healthcare providers about any history of severe drug reactions.
Attend follow-up appointments, especially if the eyes or other mucous membranes were affected, as long-term complications may require ongoing care.
FUTURE DIRECTIONS
Research is focused on:
Earlier diagnostic biomarkers
Personalized approaches to identifying high-risk drug reactions
Targeted immunomodulatory therapies
Improved wound care techniques
Strategies to reduce long-term complications and improve recovery
ENGAGEMENT QUESTION
Which advancement do you think could have the greatest impact on improving outcomes in severe skin reactions: earlier diagnosis, genetic screening for drug sensitivity, targeted immunotherapies, or advances in supportive care?